集中生长因子诱导ER压力和亡,通过增加胺生成在选定的瘤细胞系
Andrea Palermo1, Francesco Spedicato2, Anna Giudetti2
1Department of Experimental Medicine (DiMeS), University of Salento, Lecce, Italy.
Journal of cellular and molecular medicine
|October 24, 2025
概括
缩生长因子受条件介质 (CGF-CM) 选择性地杀死某些乳腺癌和骨髓瘤癌细胞. 这种癌细胞死亡涉及线粒体功能障碍,内质网膜压力和改变的脂质代谢.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 缩生长因子 (CGF) 是一种用于再生医学和癌症手术的自主生物材料.
- 它的治疗潜力需要在瘤学中进行安全评估,因为它由细胞因子,血小板和细胞组成.
研究的目的:
- 研究CGF-CM对乳腺癌 (MCF7,MDA-231) 和骨肉瘤 (SaOS-2,MG-63) 细胞系的影响.
- 阐明CGF-CM对癌细胞活力和平衡作用的潜在机制.
主要方法:
- 对MCF7,MDA-231,SaOS-2和MG-63细胞系暴露于CGF-CM.
- 细胞毒性评估,细胞亡标志物 (BAX/BCL-2比,细胞染色体c释放),脂质水平 (胺,甘油三),细胞内膜网膜 (ER) 应激标志物 (ATF6,XBP1) 和自流 (LC3,p62) 的评估.
主要成果:
- CGF-CM对MCF7和SaOS-2细胞表现出选择性细胞毒性,但对MDA-231或MG-63细胞没有.
- 敏感细胞的亡与线粒体功能障碍,胺和甘油三水平的增加,ER压力和抑制的自流有关.
- 特定的分子通路包括BAX/BCL-2比率,细胞染色体c释放,ATF6,XBP1,LC3和p62被CGF-CM调节.
结论:
- CGF-CM对特定的乳腺癌和骨髓瘤细胞系产生选择性细胞毒性作用.
- 观察到的癌细胞死亡是由线粒体功能障碍,ER压力,破坏自和改变脂质代谢的复杂相互作用介导的.
- 这些发现为CGF-CM的潜在抗癌机制提供了洞察力,并强调了在瘤学应用中需要进一步调查的必要性.
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Extrinsic Apoptotic Pathway
8.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K


